Edition:
United Kingdom

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

3.40USD
20 Jun 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.40
Open
$3.42
Day's High
$3.47
Day's Low
$3.36
Volume
119,218
Avg. Vol
179,340
52-wk High
$4.51
52-wk Low
$2.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.056
FY 2017 Dec '17 0.00 -0.059
Sep '17 0.00 -0.049
Jun '17 0.00 -0.046
Mar '17 0.00 -0.060
FY 2016 Dec '16 0.00 -0.050
Sep '16 0.00 -0.048
Jun '16 0.00 -0.055
Mar '16 0.00 -0.065
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.76 2.28 0.00 9.87
Year Ending Dec-19 3 35.16 43.70 23.70 43.88
Earnings (per share)
Quarter Ending Jun-18 3 -0.07 -0.06 -0.09 -0.06
Quarter Ending Sep-18 3 -0.08 -0.06 -0.09 -0.06
Year Ending Dec-18 3 -0.34 -0.25 -0.39 -0.23
Year Ending Dec-19 3 -0.08 -0.03 -0.12 -0.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta 1.63 0.91 0.88
Price to Sales (TTM) -- 109.18 5.71
Price to Book (MRQ) 6.89 13.44 5.37
Price to Tangible Book (MRQ) 6.89 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 41.23 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago -- 77.35 5.68
Sales - 5 Yr. Growth Rate -- 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 16.13 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago 16.48 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate 92.65 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 19.43 5.26 2.98
LT Debt to Equity (MRQ) 0.00 24.54 12.19
Total Debt to Equity (MRQ) 0.00 26.17 16.46
Interest Coverage (TTM) -- -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -564.12 10.98
Operating Margin (TTM) -- -706.11 4.74
Operating Margin - 5 Yr. Avg. -- -585.15 6.41
Pre-Tax Margin (TTM) -- -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -- -588.45 6.83
Net Profit Margin (TTM) -- -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -- -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,312,275 846,855,612
Net Income/Employee (TTM) -942,463 2,947,385 99,619,380
Receivable Turnover (TTM) -- 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.95 -0.70 10.95
Return on Assets - 5 Yr. Avg. -41.17 -0.06 12.32
Return on Investment (TTM) -42.00 2.00 14.38
Return on Investment - 5 Yr. Avg. -45.02 2.81 16.11
Return on Equity (TTM) -42.26 3.49 16.08
Return on Equity - 5 Yr. Avg. -47.24 4.33 17.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catalyst Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.88%
# of Holders: 118
Total Shares Held: 55,277,515
3 Mo. Net Change: -1,616,183
# New Positions: 20
# Closed Positions: 32
# Increased Positions: 72
# Reduced Positions: 52
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.